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ABSTRACT 
Glutamate is the major excitatory neurotransmitter in the central nervous system binding to a 
variety of glutamate receptors. Metabotropic glutamate receptors (mGluR1 to mGluR8) can 
act excitatory or inhibitory, depending on associated signal cascades. Expression and 
localization of inhibitory acting mGluRs at inner hair cells (IHC) in the cochlea is largely 
unknown. Here, we analysed expression of mGluR2, mGluR3, mGluR4, mGluR6, mGluR7 
and mGluR8 and investigated their localization in respect to the pre-synaptic ribbon of IHC 
synapses. We detected transcripts for mGluR2, mGluR3, mGluR4, and for mGluR7a, 
mGluR7b, mGluR8a and mGluR8b splice-variants. Using receptor specific antibodies in 
cochlear wholemounts, we found expression of mGluR2, mGluR4 and mGluR8b close to pre-
synaptic ribbons. Super resolution and confocal microscopy in combination with 3D 
reconstructions indicated a post-synaptic localization of mGluR2 that overlaps with PSD95 
on dendrites of afferent type I spiral ganglion neurons. In contrast, mGluR4 and mGluR8b 
were expressed at the pre-synapse close to IHC ribbons. In summary, we localized in detail 
three mGluR types at IHC ribbon synapses, providing a fundament for new therapeutical 


















Within the mammalian cochlea the mechanosensory hair cells are typically organized into a 
single row of inner hair cells (IHC) and three rows of outer hair cells (OHC). While IHC are 
connected predominantly by afferences of bipolar type I spiral ganglion neurons that transmit 
the acoustic information to the brain stem, OHC mostly contact efferent neurons and are 
believed to function as cochlear amplifiers [1]. Upon stimulation, ribbon synapses of hair cells 
release the excitatory neurotransmitter glutamate that binds to ionotropic (ion channel 
associated) and metabotropic (G-protein coupled) glutamate receptors. 
Ionotropic glutamate receptors preferentially mediate fast excitatory synaptic transmission, 
while metabotropic glutamate receptors (mGluRs) modulate neuronal excitability, synaptic 
plasticity and transmitter release [2]. The eight known mGluR types are subdivided into three 
groups: Group I - mGluR1 and mGluR5, group II - mGluR2 and mGluR3, group III - mGluR4, 
mGluR6, mGluR7 and mGluR8 [3]. While group I receptors positively modulate the activity at 
glutamatergic synapses, members of group II and group III preferentially reduce 
neurotransmitter release. These diverse functions can be derived from their specific 
expression at glutamatergic synapses: Generally, group I receptors are expressed at the 
post-synapse, members of group II were found both pre- and post-synaptically and group III 
mGluR types show a clear preference for the pre-synaptic terminal [4]. An exception is 
mGluR6: Within the central nervous system this receptor is expressed exclusively in the 
retina at post-synaptic sites of ON bipolar cells [5].  
While the cochlear distribution and function of ionotropic glutamate receptors is well 
described (see e.g. [6,7]), most studies analysing their metabotropic counterparts focussed 
on the group I receptors mGluR1 and mGluR5 (see e.g. [8]). Much less is known about 
receptors belonging to group II (mGluR2 and mGluR3) and group III (mGluR4, mGluR7 and 
mGluR8) types in the cochlea: One study suggested the presence of group II mGluRs in 
efferent lateral olivocochlear GABAergic fibres that in turn inhibit dopaminergic efferences 
signalling onto IHC afferences [9]. Polymorphisms in mGluR7 were correlated with age-
related hearing deficits or noise-induced hearing loss in humans [10-13]. Furthermore, a 
general expression of mGluR7 and mGluR8 in inner and outer hair cells was observed, but a 
synaptic localization of the receptors was not investigated [12,14]. Obviously, a 
comprehensive study regarding expression and synaptic localization of group II/III receptors 
in the cochlea is missing. 
Therefore, here we analysed the expression of the group II and group III mGluR types in the 
mouse cochlea. In addition, we investigated in detail the distribution of corresponding 
receptor proteins with respect to the pre-synaptic ribbon of IHC in cochlear wholemounts of 
adult gerbils and mice. Group II and group III mGluR types are predestinated to protect 
against excitotoxic effects caused by over-stimulation and excessive glutamate release from 
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IHC, which could cause neurodegeneration and hearing impairment [15,16]. Thus, our 
detailed description of group II and III mGluRs at IHC ribbon synapses offers new 





























Group II and group III metabotropic glutamate receptors are expressed in the mouse 
cochlea 
Several studies describe functions of group I mGluRs (mGluR1 and mGluR5) in the cochlea 
(see e.g. [8]). However, there are no comprehensive studies regarding expression of group II 
and III receptors in this tissue. Therefore, here we analysed in detail expression and 
localization of group II (mGluR2, mGluR3) and group III (mGluR4, mGluR6, mGluR7, 
mGluR8) receptors in the cochlea of mouse and gerbil.  
To pave the ground for successive anatomical studies, we first tested the presence of group 
II and III mGluR types in the mouse cochlea, including common splice variants. Fig. 1 shows 
specific PCR amplificates for mGluR2, mGluR3, mGluR4 and for the receptor isoforms 
mGluR7a, mGluR7b and mGluR8a and mGluR8b. MGluR6 was not detectable in the 
cochlea, in line with its specific expression in bipolar cells of the retina within the central 
nervous system [5]. 
Next, we analysed the distribution of cochlear group II and III mGluRs with respect to the 
ribbon synapse of IHC. Our studies were guided by the quality and specificity of available 
immune sera. We used antibodies recognizing a conserved epitope in mGluR2 and mGluR3, 
in the following designated mGluR2/3, antibodies specific for mGluR2, mGluR3, mGluR4 and 
immune sera detecting mGluR8a or mGluR8b isoforms. Antibodies for mGluR2/3, mGluR4, 
mGluR8a and mGluR8b were well characterized and used before by several groups, 
including ourselves and thus are supposed to be specific [17-19]. Nevertheless, we again 
tested the quality of the immunsera using primary cultures of cortical neurons and antibodies 
binding Shank 2 to label post-synaptic sites (Fig. S1). The immune serum used in the past to 
detect mGluR7 in neuronal tissue, e.g. the retina [20] is not available anymore. Since 
currently available immune sera cannot reproduce the original data, mGluR7 was omitted 
from our studies.  
 
Group II mGluR types show a synaptic expression in cochlear wholemounts 
The antibodies recognizing a conserved epitope in the group II receptors mGluR2 and 
mGluR3 (mGluR2/3) bind to a linear stretch of amino acids conserved in their C-termini, 
preventing a distinction between these two mGluR types. While mGluR2 or mGluR3 specific 
antibodies are available, these sera are less characterized. Therefore, we performed all initial 
studies involving 3D reconstructions with the reliable mGluR2/3 serum, while the identity of 
the group II mGluR type was determined in separate stainings using antibodies specific for 
mGluR2 or mGluR3. 
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Gerbils are a well studied animal model in hearing resaerch. Thus, we marked pre-synaptic 
sites of IHC in cochlear wholemounts of the gerbil by antibodies specific for CtBP2/RIBEYE, 
the main protein of synaptic ribbons [21]. Co-labelling the same tissue for mGluR2/3 resulted 
in a punctate label that was always observed in close vicinity to the CtBP2 positive pre-
synaptic ribbon of IHC (Figs. 2A, 2B). Given the prominent signal intensity for mGluR2/3, we 
next analysed the distribution of the receptors in the much smaller mouse cochlea (Figs. 2C, 
2D). Comparing the spatial distribution of the relative signal intensities obtained for 
mGluR2/3 and CtBP2 showed a partial overlap of both signals (Figs. 2 b’, b’’, d’, d’’). This 
observation would be consistent with 2 possible localizations of mGluR2/3 relative to the 
synaptic cleft: (i) a pre-synaptic expression outside the active zone towards the annulus of 
the pre-synaptic terminal, or (ii) a post-synaptic expression of mGluR2/3 opposite to the pre-
synaptic ribbon. 
 
Signals for mGluR2/3 are present at post-synaptic sites of inner hair cell ribbon 
synapses 
Since the mGluR2/3 staining patterns were comparable between the gerbil and mouse, in the 
following we used mouse tissue only. To distinguish between a pre- versus post-synaptic 
expression of mGluR2/3 at IHC synapses, we analysed the receptors´ distribution in more 
detail using stimulated emission depletion (STED) microscopy. Cochlear wholemounts from 
mouse were co-stained with antibodies recognizing mGluR2/3 and the CtBP2/RIBEYE 
immune serum used above, which marks the pre-synaptic ribbon (Fig. 3A-E). To stain post-
synaptic specializations formed by afferent type I spiral ganglion neurons that are located 
opposite to the pre-synaptic ribbon we used antibodies recognizing the post-synaptic density 
protein PSD95 [22] (Fig. 3A and 3F-H). Z-stacks obtained from dual-colour STED 
microscopy were 3D reconstructed and distances from the centres of gravity were measured, 
as exemplified by the dots shown in Fig. 3C and 3F. While the mean distance between 
mGluR2/3 and pre-synaptic ribbons was between 138 to 428 nm (mean of 258 ± 88.6 nm), 
the distance between the receptors and PSD95 was significantly smaller (81.8 ± 31.0 nm; 
Fig. 3I). These data favour a post-synaptic expression of mGluR2/3, slightly displaced from 
the PSD95 labelled active zone. 
In order to strengthen this assumption, we labelled simultaneously pre- and post-synaptic 
terminals using the marker antibodies shown in Fig. 4A and compared resulting fluorescent 
signals with the expression of mGluR2/3. Unfortunately, the available STED microscope 
allowed the simultaneous detection of 2 colour channels only. Therefore, we switched back 
to classical confocal microscopy in combination with 3D reconstruction. Cochlear 
wholemounts of mice were incubated with antibodies binding to mGluR2/3, CtBP2/RIBEYE 
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and PSD95 and the geometry of individually labelled synapses was 3D reconstructed from 
the confocal images (Fig. 4A, B). Reconstructions of the CtBP2/RIBEYE label showed that 
the size of the pre-synaptic ribbons was elongated into one direction, a feature that was 
observed by other groups before [23]. This is represented in Figs. 4C and 4D that compare 
the same synapse horizontally rotated by about 90 degrees. Examples of more ribbon 
synapses are summarized in Fig. 4E. In all synapses analysed, we observed a clear overlap 
of mGluR2/3 with the post-synaptic marker PSD95, which was clearly separated from the 
pre-synaptic CtBP2/RIBEYE labelled ribbon.  
Interestingly, mGluR2/3 was not completely co-localized with PSD95, but always shifted 
laterally. PSD95 marks the active zone within synapses that contains e.g. AMPA type 
glutamate receptors, while mGluR2/3 seem to be expressed just adjacent to the release site 
of glutamate. To quantify these observations, we calculated the centres of gravity for 
reconstructed signals of CtBP2/RIBEYE, PSD95 and mGluR2/3 at more than 40 individual 
ribbon synapses, represented by white dots as shown in Fig. 4D. The mean distance 
between the pre- and post-synaptic markers CtBP2/RIBEYE and PSD95 (274 ± 89.0 nm) 
was comparable to the distance between CtBP2 and mGluR2/3 (279 ± 86.1 nm; Fig. 4F). In 
contrast, the mean distance between PSD95 and mGluR2/3 was significantly shorter (164 ± 
32.2 nm), indicating that these 2 proteins are localized at the same side of the synaptic cleft. 
Calculating the angels between the 3 centres of gravity showed similar values for beta (74.0 
± 19.8 degrees) and gamma (71.4 ± 22.8 degrees; Figs. 4F) that were significantly different 
from alpha (34.6 ± 10.8 degrees), being consistent with a post-synaptic localization of 
mGluR2/3. 
Next, we exchanged CtBP2/RIBEYE with Bassoon as another pre-synaptic marker that is 
involved in anchoring the ribbon to the pre-synaptic membrane (Fig. 4A) [23,24]. Label for 
mGluR2/3 did overlap with PSD95, but not with Bassoon (Fig. 4G). Measuring distances and 
angles between the centres of gravity of signals obtained from several synapses suggested 
that mGluR2/3 are present in close vicinity to PSD95 (mean of 140 ± 24.8 nm), while being 
significantly more distant to Bassoon (mean of 272 ± 104 nm) (Fig. 4H). As before, the 
closest angle was alpha (34.3 ± 15.9 degrees), being significantly smaller that beta (66.9 ± 
21.2 degrees), or gamma (78.8 ± 17.1 degrees). Our data are consistent with mGluR2/3 
being localized at the same side of the synaptic cleft as PSD95. We conclude that mGluR2/3 





Expression of mGluR2/3 does not change along the tonotopic axis 
It has been shown that the number of ribbon synapses per IHC varies along the tonotopic 
axis in the cochlea of mouse and gerbil [25]. Therefore, we asked if the expression of 
mGluR2/3 at these synapses might also change along the spectral gradient. To this end, we 
co-stained cochlear wholemounts of mice for CtBP2/RIBEYE and mGluR2/3, as above. 
Three different tonotopic locations of the cochlea (apex, medial and base) were selected and 
the number of fluorescent puncta representing CtBP2/RIBEYE or mGluR2/3 were counted, 
as indicated in Fig. 5A to C. Finally, the number mGluR2/3 positive puncta obtained from the 
individual micrographs was normalized to the number of detected IHC ribbons. Fig. 5D 
shows that (i) we detected mGluR2/3 specific signals at 94% to 98% of IHC ribbon synapses 
and (ii) that these numbers did not change significantly along the tonotopic axis. 
  
 
MGluR2/3 specific signals are not present at efferent terminals contacting IHC 
synapses 
Previously, mGluR2/3 were proposed to be expressed by GABAergic neurons that inhibit 
dopaminergic efferences [9]. Although expression of these receptors was not detected 
directly, the authors suggested that group II mGluRs could be activated by a spill-over of 
glutamate released from the nearby IHC ribbon synapse. This, in turn would reduce the 
release of GABA, leading to a disinhibition in dopaminergic terminals. Thus, we tested if the 
lateral shift observed in the localization of mGluR2/3 in respect to PSD95 (see Figs. 3F to I 
and 4C to H) could be explained by the expression of the receptors in efferent terminals 
contacting the IHC ribbon synapse, rather than being present at the afferent IHC post-
synapse. To this end, we marked olivocochlear efferent terminals with antibodies recognizing 
Synapsin 1 [26]. Co-staining cochlear wholemounts from mice for mGluR2/3, Synapsin 1, 
CtBP2/RIBEYE and PSD95 in different combinations did not show any obvious co-
localization of the receptors with Synapsin 1 labelled efferent terminals (Fig. 6A - D). While 
we cannot rule out a low expression level at olivocochlear efferent terminals, we conclude 
that the majority of mGluR2/3 is present at the IHC post-synapse. 
 
MGluR2, but not mGluR3 can be detected at IHC ribbon synapses 
The mGluR2/3 immune serum used in this study was generated against a C-terminal 
sequence from mGluR2 that is highly conserved in mGluR3. Since we detected transcripts 
for both group II receptors in the cochlea (see Fig. 1), we next investigated if both receptors 
would be actually present at IHC synapses, using receptor specific antibodies. Because the 
mGluR2 and mGluR3 specific immune sera are not used to the same extend in the scientific 
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literature as the well-established mGluR2/3 serum, we ensured that the antibodies would be 
receptor specific and able to bind to the native receptor epitope in neurons, using HEK-293 
cells and cortical neurons in culture (Figs. S1 and S2).  
Co-staining of cochlear wholemounts for CtBP2/RIBEYE, mGluR2 or mGluR3 showed that 
only signals derived from the mGluR2/3 and mGluR2 sera were detectable in close vicinity to 
IHC ribbons (Fig. 7A-D). In contrast, mGluR3 fluorescence appeared more diffuse and was 
not co-localized with synaptic ribbons (Fig. 7E). Given the lower intensity of mGluR3 specific 
signals in the cochlea, we tested this serum on cortical neurons, as mentioned in the 
previous paragraph. Co-labelling synapses for the post-synaptic marker protein Shank 2 
showed a co-localization with the binding sites of the mGluR3 antibodies (Fig. 7F), indicating 
that the serum is able to recognize the native receptor epitope in a neuronal context. This 
observation is in agreement with previous studies that described mGluR3 in primary cultures 
of cortical neurons [27,28]. These data suggest that mGluR2, but not mGluR3 is present at 
the post-synaptic side of IHC ribbon synapses. 
 
MGluR4 and mGluR8b are expressed at the pre-synaptic side of IHC ribbon synapses 
Finally, we analysed the localization of mGluR4, mGluR8a and mGluR8b in the cochlea. 
Immune sera for mGluR4 and mGluR8b were demonstrated before to specifically recognise 
their target proteins (Corti et al. 2002, Ferraguti et al. 2005). Here, we tested if the mGluR8a 
serum would be reliable, as well. Using HEK-293 cells and cortical neurons in culture, we 
showed that the mGluR8a antibodies do not bind to mGluR8b and that they recognize the 
native receptor epitope in neurons (Figs. S1 and S3).  
These immune sera were then applied to cochlear wholemounts and pre-and post-synaptic 
specializations were marked for CtBP2/RIBEYE and PSD95, as before. Fluorescent signals 
representing the different mGluR types appeared as puncta, indicating a synaptic localization 
of these receptors (Figs. 8A, 9A and 9B). However, only mGluR4 and mGluR8b, but not 
mGluR8a were in close vicinity to CtBP2/RIBEYE and PSD95. Interestingly, in contrast to the 
partial overlap of mGluR2/3 with the pre-synaptic ribbon at IHC ribbon synapses shown in 
Fig. 4, signals representing mGluR4 or mGluR8b are completely superimposed with the pre-
synaptic ribbon marker CtBP2/RIBEYE (Fig. 8B, 9C), while overlapping only partially with the 
post-synaptic PSD95 (Fig. 8C, 9D). This suggested a pre-synaptic localization of the two 
receptors at IHC ribbon synapses.  
Indeed, after reconstructing the geometry of the labelled proteins at individual synapses, we 
observed a clear overlap of mGluR4 and mGluR8b with the pre-synaptic CtBP2/RIBEYE 
labelled ribbon, while the receptors were more distant to the post-synaptic marker PSD95 
(Figs. 8D, E and 9E, F). As before, the centres of gravity of the reconstructed fluorescent 
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labels representing the receptors, CtBP2/RIBEYE or PSD95 were calculated for individual 
ribbon synapses and distances and angles between these centres were measured, as 
indicated in Figs. 8D and 9E. The mean distance between mGluR4 or mGluR8b and the pre-
synaptic marker CtBP2/RIBEYE was significantly shorter (mGluR4: 108 ± 23.4 nm; 
mGluR8b: 119 ± 54.5 nm) than the distance between the receptors and the post-synaptic 
label (mGluR4: 373 ± 123 nm; mGluR8b: 317 ± 53.9 nm; Figs. 8F and 9G). Comparing the 
angels between the 3 centres of gravity revealed the smallest number at the gravity centre 
for PSD95 (mGluR4: 14.7 ± 9.1 degrees; mGluR8b: 20.5 ± 10.8 degrees; Figs. 8G and 9H). 
























In sensory organs like retina and cochlea, the intensity of a given stimulus is encoded by the 
graded amount of the neurotransmitter glutamate released at ribbon synapses of 
photoreceptors or inner hair cells (IHC), respectively. While expression and function of the 
inhibitory group II and III mGluR types at the photoreceptor ribbon synapse is well described 
(see e.g. [29,30]), much less information is available for the ribbon synapse of IHC. Here we 
analysed the expression and localization of group II and III mGluRs in cochlear wholemounts 
in respect to the pre-synaptic ribbon of IHC.  
We identified transcripts encoding mGluR2, mGluR3, mGluR4, as well as common mGluR7 
and mGluR8 isoforms in the mouse cochlea. Furthermore, we localized mGluR2, mGluR4 
and mGluR8b proteins at pre- or post-synaptic sides of the IHC ribbon synapse. A distinction 
between pre- and post-synaptic receptor expression was facilitated by the fact that the used 
antibodies recognize an epitope in the intracellular C-termini of mGluR2, mGluR4 and 
mGluR8b. Thus, corresponding labels appear at the intracellular sides of pre- or post-
synaptic membranes, resulting in the maximal possible distance between the two 
compartments. Indeed, we could clearly separate pre- and post-synaptic marker proteins by 
our microscopy techniques. 
MGluR2 was present at post-synaptic afferent processes of type I spiral ganglion neurons 
that contact the IHC ribbon synapse. There, mGluR2 specific signals partially overlapped 
with the post-synaptic marker protein PSD95. While PSD95 was located opposite to the pre-
synaptic ribbon, as described before [31], mGluR2 specific labelling was shifted laterally. 
This is in agreement with the idea that group II mGluRs are generally located outside the 
active zone of glutamatergic synapses [32]. A pre-synaptic expression of group II mGluRs is 
widely accepted [33]. A recent study analysing group II receptors in layer III of the primate 
dorsolateral prefrontal cortex found mGluR2 mostly at the pre-synapse of glutamatergic 
neurons, while mGluR3 was expressed preferentially at the post-synaptic specializations of 
spines [34]. The authors conclude that mGluR2 functions predominantly as autoreceptor, 
reducing neuronal excitation and glutamate release upon activation. However, in other CNS 
regions, mGluR2 was observed at post-synaptic sites [4,35-37]. Our study ads ribbon 
synapses of IHC as another location within the CNS that shows a post-synaptic expression 
of mGluR2.  
Besides cochlear hair cells, also photoreceptors and bipolar cells of the retina form ribbon 
synapses [38]. In both tissues, mGluR2 was observed at the post-synaptic side of ribbon 
synapses, while mGluR3 was absent from this synapse type (this study and [37,39]). Unlike 
the cochlea however, in the retina mGluR2 is not present at the ribbon synapse of sensory 
cells (photoreceptors), but expressed at ribbon synapses formed by second order neurons, 
designated as bipolar cells [37]. 
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In contrast to mGluR2, we detected mGluR4 at the pre-synaptic side of IHC ribbon synapses. 
Again, the situation is different in the retina. Ribbon synapses of photoreceptors in the 
mammalian retina do not express mGluR4. Instead, this receptor is present at the post-
synaptic side of ribbon synapses formed by bipolar cells, similar to mGluR2, as described in 
the previous paragraph [37,40].  
Ribbon synapses of photoreceptors express mGluR8 at their pre-synaptic site [29]. There, 
the receptor functions as integral part of a negative feed-back loop, reducing intracellular 
calcium concentrations via a pertussis toxin sensitive G-protein, thereby regulating the 
glutamate concentration in the synaptic cleft [41]. The immune serum used was directed 
against 19 amino acids in the C-terminus of the mGluR8a isoform (residues 890–908: 
ETNTSSTKTTYISYSDHSI) [29]. While the N-terminal 3 amino acids are identical between 
mGluR8a and mGluR8b, the remaining sequence is specific for the mGluR8a isoform. Thus, 
we assume that in this study actually the distribution of mGluR8a, not mGluR8b was 
described. We are not aware of any previous study describing in detail the localization of 
mGluR8b at ribbon synapses in the CNS, or of mGluR8b associated signal cascades. 
Recently, we identified cytosolic proteins that bind to mGluR8 types in an isoform specific 
way: CRIP1a regulated the endocytosis behaviour of mGluR8a, but not of mGluR8b [42]. 
While CRIP1a was detected at the photoreceptor pre-synapse [43], its expression in the 
cochlea has not been investigated. In contrast to CRIP1a, the SUMO E3-ligases PIAS1 and 
PIAS3L interacted only with the mGluR8b isoform, but not with mGluR8a [44]. Thus, we 
speculate that IHC in the cochlea and photoreceptors in the retina express different mGluR8 
isoforms at their ribbon synapses that permit a distinct regulation of associated signal 
cascades. 
In recent years it became increasingly clear that mGluRs exist as constitutive dimers [45]. 
Dimerization of mGluRs seems to be a pre-requisite for receptor activation and function [46]. 
Besides the formation of homodimers, the authors observed the assembly of different mGluR 
types into heterodimeric receptor complexes: Members of group I (mGluR1 and mGluR5) 
can form homo- and heterodimers with themselves, but not with group II or III receptors. Vice 
versa, most of the group II and III receptors can form homo- and heterodimers with partners 
of these 2 groups, but not with group I receptors. While the above mentioned receptor dimers 
were observed using heterologous expressed receptors in cell lines [47], the existence of 
mGluR2/mGluR4 heterodimers was shown in neurons [48]. We observed mGluR2 and 
mGluR4 at opposite sides of the synaptic cleft, excluding a heterodimerization between these 
two receptors at the IHC ribbon synapse. On the other hand, mGluR4 and mGluR8b are both 
expressed pre-synaptically, in principle enabling the formation of heterodimers. 
Unfortunately, the nature of available immune sera prevented direct co-localization of 
mGluR4 and mGluR8b. 
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Certain mGluRs heterodimerize with other GPCR types, including serotonin, dopamine and 
adenosine receptors [49]. MGluR2 forms heterodimers with the 5-HT2A serotonin receptor 
using 3 amino acids present within the receptors transmembrane domain 4 [50,51]. However, 
5-HT2A receptors are not expressed in the mouse cochlea [52]. While serotonin and 
serotonin synthetizing enzymes, such as tryptophan hydroxylase were detected in afferent 
spinal ganglion neurons (see e.g. [53]), we found no evidence in the literature that these 
neurons express serotonin receptors at ribbon synapses of IHC in the cochlea. In contrast to 
the cochlea, ribbon synapses of photoreceptors and bipolar cells in the rabbit retina do 
express 5-HT2A receptors [54]. 
For proper function, mGluRs interact with a variety of intracellular binding partners that 
regulate receptor trafficking, their synaptic localization, agonist sensitivity and desensitization 
behavior, as well as the efficacy of G-protein coupling [55]. Several proteins binding to the 
intracellular C-termini of mGluR2, mGluR4 and mGluR8b were identified by us and others, 
including the aforementioned CRIP1a and E3-ligases of the SUMOylation cascade, as well 
as GRIP, PICK1, Syntenin and cytoskeleton associated proteins such as MAP1B and band 
4.1 proteins [42,44,56,57]. Of these, band 4.1 proteins were detected in IHC of the mouse 
cochlea and associated with hearing deficits [58,59]. The authors localized band 4.1B, 4.1G, 
4.1N and 4.1R at stereocilia and point out the 4.1R interacts with myosin XV and with whirlin, 
two proteins associated with deafness. Previously, we described band 4.1 proteins as new 
binding partners of mGluR8 isoforms [57]. Upon binding, 4.1B increased the surface 
expression of mGluR8b and inhibited the receptors´ G-protein signaling. Although the 
presence of band 4.1 proteins at IHC ribbon synapses has not been analyzed so far, the 
above cited studies show that all four band 4.1 proteins are expressed in IHC, in principle 
enabling an interaction with and a regulation of mGluR8b. 
Our 3D reconstructions of CtBP2 fluorescent signals showed that the pre-synaptic ribbon is 
elongated into one direction, which has been described previously [23,25]. Based on electron 
microscopic data from IHC ribbons located in the midchochlear region, Meyer and co-
workers calculated mean values for the long (228 ± 60 nm) and short (118 ± 27 nm) axis of 
the pre-synaptic ribbon. In addition, the post-synaptic density opposite to the pre-synaptic 
ribbon of IHC was measured to be about 610nm in length [23]. Although a detailed 
evaluation of the dimensions of the pre- and post-synaptic structures was not of principle 
interest of this study, the geometry of our 3D reconstructions for CtBP2 and PSD95 are in 
agreement the studies cited above.  
A recent study describes functional roles of Gαi proteins at IHC ribbon synapses, 
influenceing synaptic ribbons, synapse size and neuronal excitability [60]. The authors 
showed that disruption of Gαi3 signalling increased the number of calcium channel clusters 
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and the size of the active zone. Since mGluR2, mGluR4 and mGluR8b can signal via Gαi 
proteins, these receptors might guide the activity of Gαi3 in IHC.  
Defects in hearing or vision were not reported in mice lacking mGluR2, mGluR3, mGluR4 
and mGluR8 (see e.g. [40,61-64]). This indicates that these receptors are not primarily 
involved in transmitting sensory information to higher brain areas, but might be more relevant 
in modulating more general aspects in sensory neurons, e.g. synaptic sensitivity. In doing so, 
the receptors could protect IHC ribbon synapses against over-stimulation and resulting 
excitotoxic effects. Besides a genetic predisposition and inflammation, also mechanical insult 
such as noise trauma can disturb and lead to a dysfunction of the cochlear neurotransmitter 
systems [65,66]. Intense acoustic stimuli cause a strong pre-synaptic glutamate release at 
the IHC ribbon synapse, which could over-stimulate post-synaptic ionotropic glutamate 
receptors [23,25]. This in turn would result in an unphysiologically high influx of calcium ions 
into post-synaptic terminals, leading to an over-excitation of spiral ganglion neurons. 
Furthermore, unphysiologically high calcium concentrations can activate intracellular signal 
pathways that induce apoptotic cell death, ultimately leading to acute hearing loss [65,67,68]. 
Fortunately, besides efferent innervations formed by inhibitory olivocochlear reflex loops [69], 
the cochlea contains inhibitory feedback loops organized locally at synapses that regulate 
activity and survival of sensory neurons and protect against noxious stimuli and excitotoxicity 
[70]. The detected mGluR2, mGluR4 and mGluR8b at the IHC ribbon synapse are well suited 
for this task, since these receptors can invert the activity of the excitatory neurotransmitter 














MATERIALS AND METHODS 
Experiments were carried out in accordance with the guidelines of the University Erlangen-
Nürnberg and the Deutsche Forschungsgemeinschaft. 
 
Molecular biology 
For RNA isolation, cochleae were dissected from the temporal bone and immediately frozen 
in liquid nitrogen. Total RNA from 3 cochleae of mice was homogenized using Minilys 
Personal Homogenizer (Bertin Instruments, Montigny-le-Bretonneux, France) and extracted 
with the RNeasy Micro Kit (Qiagen, Hilden, Germany). Genomic DNA was removed by 
digestion with DNAse and cDNA synthesis was performed using the QuantiTect Reverse 
Transcription Kit (Qiagen) and random hexameres/oligo-dT. PCR amplification was 
performed with 3 µl (40 ng) reverse transcribed RNA in 50 µl of PCR-buffer (in mM: 20 Tris-
HCl, 50 KCl, 2 MgCl2, 0.2 dNTPs), 0.2pM each primer (see Tab. 1), 10 Units Taq-
polymerase (Invitrogen, Waltham, MA), pH = 8.0) in a thermocycler (Applied Biosystems, 
Foster City, CA) using the following parameters: 94°C for 2 min followed by 35 cycles at 
94°C for 45 s, 60°C for 60 s, 72°C for 60 s and a final incubation at 72°C for 10 min. Five 
microliters of each PCR-product were separated on a 1.5% agarose gel. Primer pairs amplify 
a C-terminal region of the receptor sequences and were designed to span introns to detect 
residual chromosomal DNA contaminations (Tab. 1). Primer pairs for mGluR2, 3, 4, 7a, 7b, 
8a and 8b were successfully tested with mouse brain cDNA, or with a plasmid sequence for 
the retina specific mGluR6 (not shown). Control amplifications (H2O) showed no specific 
PCR products. All PCR amplificates were identified by DNA sequencing. 
 
Immunocytochemistry 
For immunofluorescence staining, animals were sacrificed and the cochleae were dissected 
using a stereomicroscope. Thereafter, 4 % paraformaldehyde (PFA) in phosphate-buffered 
saline (PBS) was applied over the round window. Cochleae of adult gerbils were fixed for 1h 
and of adult mice (6 - 12 weeks) for 15 min on ice. Thereafter, the cochlea was opened near 
the apex, explanted and decalcified in 140 mM EDTA at 4°C overnight. Gerbil cochlea turns 
were cut into three pieces after decalcification. Samples were blocked for 1 h in 5 % horse 
serum and 0.3 % Triton X-100 in PBS. Primary antibodies were diluted in in 0.1 % horse 
serum, 0.1 % Triton X-100 in PBS and applied overnight at 4°C, as specified in Table 2. 
Secondary antibodies (Alexa Fluor-488 conjugated anti-mouse or rabbit, Cy3 or Alexa Fluor-
568 conjugated anti-mouse or guinea-pig, Alexa-Fluor-647 conjugated anti-goat or mouse 
were diluted as above with DAPI and applied for 1 h at room temperature (secondary 
antibodies were purchased from molecular probes, Invitrogen, Dianova, or Jackson 
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Immunoresearch). Finally, samples were mounted with Aqua Poly/Mount (Polysciences Inc., 
Warrington, PA).  
Fluorescent labels were visualized with a Zeiss Axio Imager Z2 (Zeiss, Oberkochen, 
Germany) equipped with an ApoTome by using ZEN blue 2012 software. Images were taken 
with a 63× objective (1.4 oil, Apochromat, Zeiss) and z-projections were calculated with ZEN 
software (Zeiss). To study three-dimensional protein distributions, images were taken with a 
Laser Scanning Microscope 710 (Zeiss) by using ZEN black 2010 software with 
corresponding imaging modules, a stack interval of 0.9 µm and a pinhole of 1 airy unit. 3D 
images were reconstructed from z-stacks using Imaris 8 (Bitplane, Concord, MA).  
For high resolution STED microscopy, anti-rabbit STAR-580 1:200 and anti-mouse STAR-
635P 1:200 (Abberior Instruments, Göttingen, Germany) were used as secondary antibodies 
and probes were mounted with mowiol dabco (Sigma-Aldrich, St. Louis, MO). Thereafter, 
cochlea wholemounts were analysed with a STED microscope (2-Channel Super Resolution 
Microscope, Abberior Instruments) equipped with with a 100× oil immersion lens (NA: 1.44). 
Probes were excited at 561nm and 640nm and stimulated emission depletion was performed 
at 775nm with a pulsed laser. Image stacks were acquired with Imspector Software (Abberior 
Instruments) in 3D STED-mode with a xyz pixel size from 90 x 90 x 90 nm. Deconvolution 
was performed in Huygens Professional 18.04 (Scientific Volume Imaging B.V., Netherlands) 
and images were reconstructed from z-stacks using Imaris 8 (Bitplane).  
All antibody incubations of mouse cochlear wholemounts were repeated between 3 and 6 
times, except incubations shown in Fig. 3. As control, cochleae were incubated with 
secondary antibodies only, which resulted in the absence of detectable fluorescence. 
Recorded fluorescent signals were assembled in Adobe Photoshop (CS5; Adobe Systems 
Inc., San Jose, CA) and contrast enhanced and enlarged, if needed for better visualization. 
 
Cell culture 
The specificity of immune sera directed against mGluR2, mGluR3, mGluR8a and mGluR8b 
was verified with HEK-293 cells transfected with plasmids encoding the receptors. HEK-293 
cells were grown in 6 well plates at 37°C and 5 % CO2 on glass coverslips coated with 
poly(L-lysine)/3-aminopropyltriethoxysilane in minimum essential media that was 
supplemented with 10% fetal bovine serum, L-glutamine and penicillin/streptomycin (Life 
Technologies, Grand Island, NY) to approximately 50 % confluency. Cells were transfected 
with 2 µg plasmid DNA encoding for the rat sequences of mGluR2 or mGluR3 (kindly 
provided by J.-P. Pin, Institut de Genomique Fonctionnelle, Montpellier, France), mGluR8a or 
mGluR8b (kindly provided by F. Ferraguti, Innsbruck, Austria) for 18 h using lipofection 
(jetPEI, Polyplus transfection, NY, USA). Thereafter, cells were washed three times with PBS 
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and incubated for another 48 h as above to allow protein expression. Then, cells were 
washed, fixed in 4 % (v/v) PFA/PBS for 10min on ice, washed again and blocked with 10 % 
(v/v) fetal bovine serum containing 2 % (w/v) bovine serum albumine and 0.1 % Triton X-100 
for 30 min. Subsequently, cells were incubated for 1.5h at room temperature with primary 
antibodies diluted in blocking solution, as indicated in Figs. S2 and S3 (see Tab. 2 for details 
of the used immune sera). After washing, secondary antibodies (Alexa Fluor-488, conjugated 
anti-mouse or rabbit, Cy3 conjugated anti-mouse or rabbit) together with DAPI were diluted 
as above and applied for 45 min hour at room temperature.  
All immune sera recognizing the different mGluR types analysed in this study were also 
tested on neurons. Cultures of cortical neurons were prepared from E18 Sprague-Dawley 
rats in Hank’s balanced salt solution as previously described [71]. In brief, the cortex 
(excluding olfactory bulb and hippocampus) was dissected, washed in Hank’s balanced salt 
solution (-Ca2+, -Mg2+) and incubated in Hank’s balanced salt solution containing trypsin for 5 
min (37°C). After trypsin removal cells were carefully dispersed in Dulbecco’s modified 
Eagle’s medium containing 10 % FCS. Cells were plated at a density of 100 x 103 cells per 
mL on poly(L-lysine) coated cover slips in a 24-well plate. Cultures were maintained in 
serum-free neurobasal medium (Invitrogen) containing GS21 supplement (Sigma) and kept 
at 37°C in 5 % CO2.  
After 14-21 days in culture, cells were washed, fixed in 4 % PFA/PBS for 10min on ice and 
incubated with immune sera recognizing the mGluR types indicated in Fig. S1 and the post-
synaptic marker protein Shank 2 (see Tab. 2 for antibody specifications) for 1.5 h at room 
temperature. The binding sites of the primary antibodies were visualized by secondary 
antibodies coupled to Alexa Fluor-488 conjugated rabbit, Alexa Fluor-568 conjugated anti- 
guinea-pig (Molecular Probes, Invitrogen). Coverslips containing stained cortical neurons 
were extensively washed and mounted with Aqua Poly/Mount (Polysciences Inc.). 
Fluorescent signals of stained HEK-293 cells and of cortical neurons were recored with a 
Zeiss Axio Imager Z2 (Zeiss) and assembled in in Adobe Photoshop (Adobe Systems Inc), 
as described above. As control, cells were incubated with a mixture of only secondary 
antibodies, which resulted in the absence of detectable signals. 
 
Data analysis 
The ImageJ tool "Plot Profile“ was used to measure fluorescence profiles in individual 
confocal images (ImageJ version 1.49g; U. S. National Institutes of Health, Bethesda, 
Maryland, USA). 3D reconstructions of fluorescent signals of z-stacks from STED or confocal 
microscopy, the definition of the centres of gravity of reconstructed signals, as well as 
distance and angle measurements were performed with Imaris (Bitplane). Obtained data sets 
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were evaluated using the Microcal Origin Software (Microcal Software, Northhampton, MA). 
Statistical significance was calculated with the one-way ANOVA test. Errors are expressed 
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Figure 1: Expression of group II and III mGluR types in the mouse cochlea. (top) 
Agarose gel showing PCR amplificates of expected size for the indicated mGluR types 
obtained from reverse transcribed transcripts purified from mouse cochlea. Expression of 
prominent C-terminal splice-variants of mGluR7 and mGluR8, termed a and b was analysed 
individually. The identity of PCR products was verified by sequencing. (bottom) Negative 
controls (H2O) show primer-dimer formations (arrowhead), but no amplificates of the 
expected sizes. The left lane shows a 100 bp marker. For better visualization, black and 
white levels of the original photograph were inversed. 
 
Figure 2: Localization of mGluR2/3 in cochlear wholemounts of gerbil and mouse. (A) 
Micrograph showing a cochlear wholemount from gerbil that was incubated with antibodies 
recognizing CtBP2/RIBEYE (red) to label the ribbon in pre-synaptic hair cell terminals and 
with DAPI (cyan) to visualize cellular nuclei. Co-staining with an immune serum recognizing a 
conserved epitope in mGluR2 and mGluR3 (mGluR2/3 - green) resulted in a punctate 
staining pattern in close vicinity to pre-synaptic ribbons. This is best seen in the magnification 
of the boxed region shown in the lower panel (B). The intensity of green and red fluorescent 
signals was measured along the white transparent arrows and compared in b´ and b´´. (C, D) 
Cochlear wholemounts from mouse were stained and analysed as described above.  
 
Figure 3: Staining for mGluR2/3 overlaps with post-synaptic, but not with pre-synaptic 
markers. (A) Sketch of an IHC ribbon synapse depicting the distribution of used marker 
proteins relative to the synaptic cleft: CtBP2/RIBEYE labels the pre-synaptic ribbon (red) that 
is surrounded by glutamatergic vesicles (white circles), while PSD95 (magenta) serves as a 
post-synaptic marker. (B) Micrograph of a cochlear wholemount from mouse incubated with 
antibodies recognizing mGluR2/3 (green) and CtBP2/RIBEYE (red) and DAPI to mark 
cellular nuclei, as analysed by dual-colour STED microscopy. (C) The geometry of 
fluorescent signals was 3D reconstructed, centres of gravity for green and red labels were 
calculated (white balls) and their distances were measured (dashed line - a). (F) Similar 
analysis as in (C), using the post-synaptic marker PSD95 (magenta) to measure distances, 
as indicated (black balls - b). (D, E, G, H) More examples of reconstructed signals. (I) Bar 
diagram comparing measured distances between mGluR2/3 and CtBP2/RIBEYE (a; n=8), or 
between mGluR2/3 and PSD95 (b; n=6). The number of synapses analysed is indicated in 
white. Three asterisks indicate a p-value < 0.0005. 
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Figure 4: Signals for mGluR2/3 are located at the IHC post-synapse, adjacent to the 
active zone. (A) Sketch of an IHC ribbon synapse showing the locations of pre-synaptic 
(CtBP2/RIBEYE - red, Bassoon – dark red) and post-synaptic (PSD95 - magenta) marker 
proteins relative to the synaptic cleft. (B) Overview of a 3D stack of confocal images from a 
cochlear wholemount of mouse that was incubated with antibodies recognizing the proteins 
indicated, or DAPI to mark cellular nuclei. The CtBP2/RIBEYE immune serum cross-reacts 
with IHC nuclei (asterisks). The background shows the same region in phase contrast (grey). 
(C) Reconstruction of the 3D geometry of fluorescent signals, as indicated. To visualize the 
distance between different labels more clearly, individual colour combinations are shown 
separately in the small panels to the right. (D) represents the same synapse as in (C), 
rotated horizontally by approximately 90 degrees. For each colour, the centre of gravity 
(white dots) was calculated, and distances and angles were measured, as indicated. (E) 
More reconstructed synapses, labelled as indicated in (C). (F) Bar diagrams summarizing 
calculated mean distances and angles between the centres of gravity of 42 synapses as 
shown in (D). White numbers represent the synapse quantity analysed. (G, H) 
Reconstruction and measurements of 13 3D reconstructed synapses as in (D, F) using 
Bassoon as pre-synaptic marker. p-values < 0.005 or 0.0005 are indicated by 2 or 3 
asterisks. 
 
Figure 5: The relation between mGluR2/3 clusters and IHC ribbons remains constant 
along the tonotopic axis. Cochlear wholemounts from mouse were incubated with 
antibodies recognizing mGluR2/3 (green) and CtBP2/RIBEYE (red). Images were taken from 
3 regions indicated by the dashed boxes in the cochlear sketch shown in the middle, 
representing high (A: apex) middle (B: median) or low (C: base) frequencies. The number of 
green clusters (representing mGluR2/3) was counted and normalized to the number of red 
clusters, representing IHC ribbons. (D) Bar diagram comparing the number of mGluR2/3 
positive clusters with the number of stained IHC ribbons. No statistical significant differences 
were observed. The number of analysed pictures for each cochlear region is given in white.  
 
Figure 6: Synapsin 1 positive efferent terminals do not express mGluR2/3. Micrographs 
of cochlear wholemounts from mouse incubated with the immune sera indicated. 
Olivocochlear efferent terminals were marked with antibodies recognizing synapsin1. (A) 
While signals representing mGluR2/3 (green) and the pre-synaptic marker CtBP2/RIBEYE 
(red) are in close vicinity, label for Synapsin 1 (cyan) was observed at different locations. (B) 
To compare the distribution of fluorescent signals, the boxed region was enlarged, intensity 
profiles were measured along the white transparent arrow and are shown in the lower panel 
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(b´). (C) Micrographs analysed as in (A), using the post-synaptic marker PSD95 (magenta) 
instead of CtBP2/RIBEYE. (D) As before, signal locations are compared along the 
transparent arrow and visualized in the lower panel (d´). 
 
Figure 7: MGluR2, but not mGluR3 is located at the IHC post-synapse. Cochlear 
wholemounts were incubated with antibodies binding CtBP2/RIBEYE (red) to mark pre-
synaptic ribbons of IHC, and with immune sera recognizing mGluR2/3 (A), mGluR2 (C) or 
mGluR3 (E) (all in green). Fluorescent signals representing mGluR2/3 and mGluR2 were 
always located at the IHC ribbon synapse. This can be best seen in the enlargements of the 
boxed regions shown in (B) and (D). Intensities of fluorescent signals were measured along 
the transparent arrows and compared in the lower panels (b´, d´). In contrast to mGluR2, the 
mGluR3 immune sera showed a more diffuse staining of low intensity within the region of 
IHC ribbon synapses. To ensure that these antibodies would recognize the native epitope of 
mGluR3, we co-stained primary cortical neurons for mGluR3 (green) and the synaptic marker 
protein Shank 2 (red) (F). Signal intensities were measured along the white arrow and 
resulting profiles are compared in f´. 
 
Figure 8: MGluR4 is located at the pre-synaptic side of IHC ribbon synapses. (A) A 
cochlear wholemount of mouse was incubated with antibodies labelling pre-synaptic 
CtBP2/RIBEYE (red) and post-synaptic PSD95 (magenta) marker proteins and co-stained 
with an immune sera recognizing mGluR4 (green). The enlargements of the boxed region 
show a perfect superimposure of signals representing mGluR4 and CtBP2/RIBEYE (B), 
while fluorescent label for mGluR4 and PSD95 were displaced (C). This can be best seen in 
the comparisons of the signal intensities measured along the transparent white arrows (b´ + 
c´, b´´ + c´´). (D) The 3D geometry of fluorescent signals was reconstructed and shown, as 
described in Fig. 4C. (E) More reconstructed synapses, labelled as in (D). At individual 
synapses the centres of gravity were calculated for each fluorescent label (black and white 
dots) and distances and angles were measured, as indicated. (F, G) Calculated mean 
distances and angles between the centres of gravity of 19 3D reconstructed synapses are 
summarized in the bar diagrams. White numbers represent the synapse number analysed. 
Three asterisks indicate a p-value < 0.0005. 
 
Figure 9: IHC ribbon synapses express mGluR8b, but not mGluR8a. Cochlear 
wholemounts of mouse were incubated with immune sera recognizing mGluR8a (A) or 
mGluR8b (B), together with antibodies binding to pre- or post-synaptic marker proteins, as 
indicated. While mGluR8a (green) was not co-localized with the pre-synaptic ribbon marker 
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CtBP2/RIBEYE (red), mGluR8b showed a perfect overlap with IHC ribbon synapses. This 
can be best seen in the two enlargements of the boxed region that compare the localization 
of mGluR8b (green) with the pre-synaptic marker protein CtBP2/RIBEYE (red) (C), or with 
the post-synaptic marker PSD95 (magenta) (D). Comparing signal intensities for all 3 colours 
as measured along the white transparent arrows shows co-localization of mGluR8b with 
CtBP2/RIBEYE, while signals representing PSD95 are displaced (c´ + d´, c´´ + d´´). (E - H) 
The 3D geometry of fluorescent signals of 19 synapses was reconstructed, their centres of 
gravity were calculated, distances and angles were measured and graphically compared in 































Table 1: Oligonucleotides used for expression analysis. 
Overview of DNA sequences of used oligonucleotides. Primers amplify a C-terminal region of 
the receptor sequences and span an intron to detect potential amplification of chromosomal 
DNA. (P1 – sense primer; P2 – antisense primer, stop codons in the antisense primers are 
underlined).  
 
  Gene   Oligonucleotide [5´!  3´]  
mGluR2 P1 - CAGTGATTATCGGGTGCAG 
 P2 - TCAAAGCGACGATGTTGTTGAG 
mGluR3 P1 - TACACCACCTGCATCATCTG 
 P2 - TCACAGAGATGAGGTGGTGG 
mGluR4 P1 - CGGCTGACAAGCTGTACATC 
 P2 - CTAGATTGCATGGTTGGTGTAAG 
mGluR6 P1 - GTATTATCTGGCTGGCTTTCG 
 P2 - CTACTTGGCGTCCTCTGAGTTC 
mGluR7a/b P1 - CACCCTGAACTCAATGTCCAG 
mGluR7a P2 - TTAGATAACCAGGTTATTATAACTG 
mGluR7b P2 - CTATACTGTTGGTGGGATAGTG 
mGluR8a/b P1 - CACGTGCATCATTTGGTTAGC 
mGluR8a P2 - TCAGATTGAATGATTACTGTAGC 












Table 2: Primary antibodies used in this study  
Overview of primary antibodies used in this study. The epitope is characterized by species 
and amino acid region, if known. (aa – amino acids; NT seq. - N-terminal sequence) 
 
Protein Epitope Dilution Serum type  Reference 
Bassoon rat Bassoon 1:  400 mouse monoclonal 
Enzo Life Sciences  
(ADI-VAM-PS003) 
CtBP2/RIBEYE mouse aa 361-445 1:  300 mouse monoclonal BD Bioscience (612044) 
CtBP2/RIBEYE rat aa 974-988 1:5000 guinea-pig polyclonal Synaptic Systems (193003) 
CtBP2/RIBEYE rat aa 95-207 1:5000 guinea-pig polyclonal Synaptic Systems (192104) 
mGluR2/3 
rat mGluR2  
aa 860-872 
1:  100 rabbit polyclonal  Merck Millipore (AB1553) 
mGluR2  NT seq. of 47 aa 1:  150 mouse monoclonal Abcam (AB15672) 
mGluR3 NT seq. of 16 aa 1:  150 rabbit polyclonal Abcam (AB188750) 
mGluR4 rat aa 834-912 1:  150 rabbit polyclonal [17] 
mGluR8 human aa 34-514 1:    50 mouse monoclonal R&D Systems (MAB5277) 
mGluR8a rat aa 886-908 1:1000 guinea-pig polyclonal Chemicon (AB5362) 
mGluR8b mouse aa 886-908 1:  150 rabbit polyclonal [18] 
PSD95 mouse aa 64-247 1:  250 mouse monoclonal Synaptic Systems (124011) 
PSD95 mouse aa 1-100 1:  100 goat polyclonal Abcam (AB12093) 
Shank 2 rat aa 1042-1475 1:1000 rabbit polyclonal Synaptic Systems (162202) 
Shank 2 rat aa 1042-1475 1:5000 guinea-pig polyclonal Synaptic Systems (162204) 








Figure S1: Verification of antibody specificity in primary cultures of cortical cells. 
Immune sera for mGluR2/3, mGluR2, mGluR3, mGluR4, mGluR8a, or mGluR8b were co-
incubated with antibodies recognizing the post-synaptic marker protein Shank 2, as 
indicated. All receptor antibodies generated green fluorescent puncta that were located at or 
close to Shank 2-positive structures (red). This can be better seen in the enlargements of the 
boxed regions that are shown in individual colours. Obvious co-localizations of fluorescent 
signals are indicated by arrowheads. DAPI visualizes cellular nuclei. 
 
Figure S2: Verification of the specificity of mGluR2 and mGluR3 immune sera in HEK-
293 cells. HEK-293 cells were transfected with plasmids encoding for mGluR2 (upper 3 
panels) or mGluR3 (lower 3 panels). Incubation with the mGluR2 immune sera stained cells 
expressing mGluR2 (A), but not cells expressing mGluR3 (B). In contrast, the mGluR3 
immune sera did not recognize cells expressing mGluR2 (C), but stained cells expressing 
mGluR3 (D). The mGluR2/3 serum served as positive control for plasmid transfection and 
protein expression (E, F). DAPI was used to visualize cellular nuclei. 
 
Figure S3: Verification of the specificity of mGluR8a and mGluR8b immune sera in 
HEK-293 cells. Plasmids encoding for mGluR8a (upper 3 panels) or mGluR8b (lower 3 
panels) were transfected in HEK-293 cells. The mGluR8a specific antibodies stained only 
cells expressing mGluR8a (A), but not mGluR8b (B). In contrast, the mGluR8b serum did not 
recognize cells expressing mGluR8a (C), but mGluR8b (D). Antibodies recognizing both 
mGluR8 variants served as positive control for plasmid transfection and protein expression 
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Supplementary Figure 1 
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Supplementary Figure 3 
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